1Q10 OnBioVC | Trend Analysis Now Available

Hot off the press! The 1Q10 OnBioVC Trend Analysis study is available for download [HERE]; and now features OnBioIPO and OnBioM&A data too!

The 1Q10 OnBioVC Trend Analysis tracked, in aggregate, 74 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $1,260.1M. Compared to 1Q09 OnBioVC data, this investment activity represents a decrease in the number of quarter-over-quarter financings by 10 (74 v. 84) and a decrease in quarter-over-quarter invested capital of $170.0M ($1,260.1M v. $1,430.3M).

Please feel free to share this document with peers and colleagues and do not forget to sign-up to receive OnBioVC, M&A and IPO deal updates at OnBioVC.com.

Many thanks to the wonderful sponsors who make OnBioVC possible. Show them your support!

Apredica - Preclinical ADME Tox Contract Research
Lockton - Lifescience Industry Specific Insurance Needs
BioWest - The Rocky Mountain Region Premiere Device & Biotech Conference
Regulus - A Full Spectrum of Regulatory Affairs and Quality Assurance Solutions
Denson Group - Executive Search Working Exclusively in Med Device Manufacturing
Colorado Bioscience Association - Advocacy. Representation. Service
Freestone Group - Integrated Solutions for Emerging Life Science
San Jose BioCenter - Giving emerging companies that Big Company Advantage…
BioBeers - Where Great Minds Drink Alike…